Source: European Journal of Pharmaceutical Sciences. Unidades: IME, FCF
Subjects: BIOEQUIVALÊNCIA, ANÁLISE DE SÉRIES TEMPORAIS
ABNT
SOARES, Kelen Carine Costa; CHIANN, Chang; STORPIRTIS, Silvia. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, Amsterdam, v. 171, n. artigo 106127, p. 1-6, 2022. Disponível em: < https://doi.org/10.1016/j.ejps.2022.106127 > DOI: 10.1016/j.ejps.2022.106127.APA
Soares, K. C. C., Chiann, C., & Storpirtis, S. (2022). Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, 171( artigo 106127), 1-6. doi:10.1016/j.ejps.2022.106127NLM
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.Available from: https://doi.org/10.1016/j.ejps.2022.106127Vancouver
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.Available from: https://doi.org/10.1016/j.ejps.2022.106127